Filing Details
- Accession Number:
- 0000950170-23-064228
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-15 17:00:14
- Reporting Period:
- 2023-11-14
- Accepted Time:
- 2023-11-15 17:00:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1816736 | Disc Medicine Inc. | IRON | Pharmaceutical Preparations (2834) | 851613057 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1951850 | Rahul Khara | C/O Disc Medicine, Inc. 321 Arsenal Street, Suite 101 Watertown MA 02472 | General Counsel | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-11-14 | 4,900 | $14.69 | 4,900 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-11-14 | 4,113 | $50.53 | 787 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-11-14 | 787 | $51.05 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-11-15 | 4,900 | $0.00 | 4,900 | $14.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 89,804 | 2032-02-06 | No | 4 | M | Direct |
Footnotes
- These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.01 to $51.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.01 to $51.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- 25% of the shares underlying this option vested on December 20, 2022, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Billionaire Hedge Funds
